BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 29, 2017
View Archived Issues
ZPIV demonstrates safety and immunogenicity in preliminary analysis of three phase I studies
Read More
CStone seeks Australian clinical trial approval to begin studies of CS-1003 and CS-3006
Read More
Patient recruitment ongoing in phase II trial of CR-6086
Read More
Phase I study of C188-9 enrolling patients with advanced cancer
Read More
FDA approves expanded indication for Procysbito to include children 1 year of age and older
Read More
Treatment with CRISPR-Cas9 improves motor function and extends survival in mouse model of ALS
Read More
Descartes-08 cells demonstrate promising antitumor effect in preclinical models of multiple myeloma
Read More
Fervent Pharmaceuticals submits IND in U.S. for FP-101
Read More
CD229 CAR T cells demonstrate strong cytotoxic activity, selectivity in models of multiple myeloma
Read More
Phase III EMBRACA study meets primary endpoint of PFS with talazoparib over chemotherapy
Read More
Caveolin-1 as a potential novel target with antimetastatic function in macrophages
Read More
GAK as a potential new therapeutic target for FBXW7-deficient tumors
Read More
TherapeuticsMD submits NDA for TX-001-HR to treat menopausal vasomotor symptoms
Read More
Odonate Therapeutics announces initiation of phase III CONTESSA study
Read More
BiondVax Pharmaceuticals planning phase III study of universal flu vaccine
Read More
FDA grants priority review to Epidiolex NDA, GW Pharmaceuticals submits MAA in Europe
Read More
Brazilian approval for Biocon and Mylan's trastuzumab biosimilar
Read More
Genexine signs licensing agreement with I-Mab for HyLeukin in Greater China
Read More
HTG Molecular Diagnostics in new master collaboration agreement with Merck KGaA
Read More
FDA approves Dermapace System to treat diabetic foot ulcers
Read More
Gilead Sciences patents farnesoid X receptor agonists
Read More
Infinity Pharmaceuticals describes PI3Kgamma/delta inhibitors
Read More
Janssen Biotech reports development of GM-CSF variants for treatment of IBD
Read More
Medshine Discovery patent describes beta-lactamase inhibitors
Read More